Dolby Laboratories (DLB) Cash from Financing Activities (2009 - 2026)

Dolby Laboratories (DLB) has reported Cash from Financing Activities for 18 consecutive years, with -$91.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Cash from Financing Activities fell 49.85% year-over-year to -$91.0 million; the trailing twelve-month figure through Jun 2026 stood at -$376.8 million (down 54.86% YoY), and the FY2025 full-year result was -$247.2 million, up 14.1% from the prior year.
• Cash from Financing Activities improved to -$91.0 million in Q2 2026 per DLB's latest filing, from -$99.9 million in the prior quarter.
• Across five years, Cash from Financing Activities topped out at -$36.8 million in Q2 2023 and bottomed at -$242.4 million in Q3 2022.
• Historically, Cash from Financing Activities has averaged -$90.1 million across 5 years, with a median of -$66.0 million in 2023.
• The sharpest annual moves came in 2022 and 2023: Cash from Financing Activities plunged 340.89% in 2022, then jumped 82.35% in 2023.
• Over 5 years, Cash from Financing Activities stood at -$90.1 million in 2022, then tumbled by 38.9% to -$125.1 million in 2023, then surged by 53.99% to -$57.6 million in 2024, then sank by 111.62% to -$121.8 million in 2025, then increased by 25.3% to -$91.0 million in 2026.
• According to Business Quant data, Cash from Financing Activities over the past three periods registered -$91.0 million, -$99.9 million, and -$121.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.